Pharmacology News and Research

Latest Pharmacology News and Research

Scientists identify new susceptibility genes in genome-wide association study of nasopharyngeal carcinoma

Scientists from Singapore, China and USA have identified three new susceptibility genes in a genome-wide association study of nasopharyngeal carcinoma (NPC). The study, led by the Genome Institute of Singapore (GIS), a biomedical research institute of the Agency for Science, Technology and Research (A*STAR), and the Sun Yat-Sen University Cancer Centre, identified genetic risk factors of NPC that advance the understanding of the important role played by host genetic variation in influencing the susceptibility to this cancer.

31 May 2010

HUYA Bioscience International forms strategic partnership with School of Chinese Materia Medica of BUCM

HUYA Bioscience International, a leader in globalizing China's biopharmaceutical innovation, today announced a strategic partnership with the School of Chinese Materia Medica of the Beijing University of Chinese Medicine (BUCM). As one of a series of collaborations that HUYA has established with China's leading research and development institutions, the agreement demonstrates HUYA's visionary commitment to enabling and accelerating the global development and commercialization of novel biopharmaceutical products originating in China.

29 May 2010

UT Southwestern researchers create 35 new rat "lines" with mutations in specific genes

For two decades, the laboratory mouse has been the workhorse of biomedical studies and the only mammal whose genes scientists could effectively and reliably manipulate to study human diseases and conditions.

28 May 2010

Designation of operating rooms as "wet" locations could prevent electrical injury to patients, OR personnel

A frightening electrical injury to an operating room nurse highlights the need to update electrical safety policies for the operating room, according to the June issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).

27 May 2010

Study assesses possible links between pain medications and recurrent breast cancer risk

Women who receive one common pain drug during mastectomy are less likely to develop recurrent breast cancer in the years following surgery, suggests a study in the June issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.

27 May 2010

Demand rises for graduates of health information technology programs

The Atlanta Journal Constitution reports that the Atlanta Technical College is expanding its health information technology program because demand for graduates is expected to grow by 20 percent through 2018.

27 May 2010

UT Southwestern Medical Center researchers identify novel chemical compounds with anti-malarial activity

As part of a multicenter study, UT Southwestern Medical Center researchers have identified a series of chemical compounds that might serve as starting points for the identification of new classes of anti-malarial drugs.

26 May 2010

NIDDK awards Albert Einstein College of Medicine $9.5M for continuation of Diabetes Research and Training Center

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) has awarded Albert Einstein College of Medicine of Yeshiva University a five-year, $9.5 million grant for the continuation of its Diabetes Research and Training Center (DRTC). The DRTC was also awarded a $632,000 supplemental grant for equipment and additional pilot and feasibility studies through the American Recovery and Reinvestment Act (ARRA), bringing total NIH support to $10,177,000.

26 May 2010

Nanoliposomes engineered to deliver therapeutic drugs that kill malignant cells

A new way to deliver cancer-fighting drugs using tiny particles made from lipids and chemotherapy drugs may have the power to knock out malignancies with a one-two punch. The strategy holds promise for patients with many different kinds of cancers.

25 May 2010

ADDF provides $248,000 grant to ALSP to allow its lead drug candidate towards clinical trials

The Alzheimer's Drug Discovery Foundation announced today that it is providing a grant of $248,000 to American Life Science Pharmaceuticals, Inc. to allow for manufacture of its lead drug candidate to be used in preclinical toxicology testing in preparation for entering Phase I clinical trials early in 2011.

25 May 2010

Bayer's Adalat XL product and Mylan's nifedipine extended release 60 mg not bioequivalent: Study

Bayer Inc. today responded to Professor Marvin Meyer's letter to the editor, entitled: "Critical questions concerning the validity of the Bayer study report of differences in bioavailability between 60 mg of nifedipine osmotic push-pull systems after fasted and fed administration" and published in the online edition of the International Journal of Clinical Pharmacology and Therapeutics. Bayer responded to the clinical relevance of the differences in formulation and dissolution behaviour and the delayed absorption of Mylan's extended release nifedipine.

25 May 2010

Phase 1 clinical trial of OXY111A initiated

NormOxys Inc., a biotechnology company developing a novel class of small molecule drugs which enhance the body's ability to deliver oxygen to diseased tissues, today announced that it has initiated a Phase 1 clinical trial of OXY111A, a novel allosteric modulator of affinity of oxygen to hemoglobin. NormOxys plans to initially develop this compound as a treatment for chronic heart failure and cancer indications.

24 May 2010

Updates on Micromet's BiTE antibody development programs to be made at two medical conferences

Micromet, Inc., a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, today announced that updates on several of its BiTE antibody development programs will be made at two upcoming medical conferences.

21 May 2010

New drug testing technique is safe and effective

A new study from the Swedish medical university Karolinska Institutet presents a new technique that makes drug testing possible through exhaled air for the first time.

21 May 2010

AACN and Elsevier/MC Strategies to develop online nursing courses

21 May 2010

Data from three Phase II clinical trials of PS-targeting antibody to be presented at 2010 ASCO Annual Meeting

Peregrine Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing innovative monoclonal antibodies for the treatment of cancer and viral infections, will present data from three Phase II clinical trials highlighting the clinical potential of its unique phosphatidylserine -targeting antibody bavituximab for the treatment of solid tumors.

21 May 2010

AACN and Elsevier/MC Strategies announce Critical Care Pharmacology online nursing course

Elsevier/MC Strategies, a pioneer in providing e-learning solutions to more than 1,300 healthcare organizations, has partnered with the American Association of Critical-Care Nurses (AACN) to develop a series of online nursing courses. Today, AACN and Elsevier/MC Strategies announced the first course in this series: AACN Critical Care Pharmacology.

20 May 2010

Mutation in BRCA1 tumor suppressor gene helps develop breast, ovarian cancer: Study

Studies have well established that women who harbor a mutation in the BRCA1 tumor suppressor gene are at greater risk for developing breast and ovarian cancers. Less known is information on other molecular events that may impact cancer formation in cells having a BRCA1 mutation. Investigators from The Cancer Institute of New Jersey and a number of major cancer centers in Europe have identified the role a key protein plays in helping cells with mutant BRCA1 genes to survive.

20 May 2010

New study shows CDPK1 controls toxoplasma's ability to secrete microneme proteins

Researchers at Washington University School of Medicine in St. Louis have identified a parasite protein that has all the makings of a microbial glass jaw: it's essential, it's vulnerable and humans have nothing like it, meaning scientists can take pharmacological swings at it with minimal fear of collateral damage.

20 May 2010

UAMS and partners receive $14.7M NIH grant for extension of biomedical research

Biomedical research in Arkansas has received a $14.7 million boost over five years from the National Institutes of Health (NIH) to continue expanding and improving biomedical research in the state.

20 May 2010

Pharmacology News and Research

Latest Pharmacology News and Research

Scientists identify new susceptibility genes in genome-wide association study of nasopharyngeal carcinoma

HUYA Bioscience International forms strategic partnership with School of Chinese Materia Medica of BUCM

UT Southwestern researchers create 35 new rat "lines" with mutations in specific genes

Designation of operating rooms as "wet" locations could prevent electrical injury to patients, OR personnel

Study assesses possible links between pain medications and recurrent breast cancer risk

Demand rises for graduates of health information technology programs

UT Southwestern Medical Center researchers identify novel chemical compounds with anti-malarial activity

NIDDK awards Albert Einstein College of Medicine $9.5M for continuation of Diabetes Research and Training Center

Nanoliposomes engineered to deliver therapeutic drugs that kill malignant cells

ADDF provides $248,000 grant to ALSP to allow its lead drug candidate towards clinical trials

Bayer's Adalat XL product and Mylan's nifedipine extended release 60 mg not bioequivalent: Study

Phase 1 clinical trial of OXY111A initiated

Updates on Micromet's BiTE antibody development programs to be made at two medical conferences

New drug testing technique is safe and effective

AACN and Elsevier/MC Strategies to develop online nursing courses

Data from three Phase II clinical trials of PS-targeting antibody to be presented at 2010 ASCO Annual Meeting

AACN and Elsevier/MC Strategies announce Critical Care Pharmacology online nursing course

Mutation in BRCA1 tumor suppressor gene helps develop breast, ovarian cancer: Study

New study shows CDPK1 controls toxoplasma's ability to secrete microneme proteins

UAMS and partners receive $14.7M NIH grant for extension of biomedical research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Pharmacology News and Research

Latest Pharmacology News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in